Production of polyclonal antibodies

Making and Using Antibodies: A Practical Handbook

Volumn , Issue , 2006, Pages 41-72

  Kendall, Lon V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61849128925     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (137)

1. Paul, W.E., Fundamental Immunology, 5th ed., Lippincott Williams & Wilkins, Philadelphia, 2003.
2. Janeway, C.A., Jr., et al., Immunobiology: The Immune System in Health and Disease, 6th ed., Garland Science, New York, 2005.
3. Moser, M., Dendritic cells, in Fundamental Immunology, 5th ed., Paul, W.E., Lippincott Williams & Wilkins, Philadelphia, 2003.
4. Gordon, S., Macrophages and the immune response, in Fundamental Immunology, 5th ed., Paul, W.E., Lippincott Williams & Wilkins, Philadelphia, 2003.
5. Lenschow, D.J., et al., CD28/B7 system of T cell costimulation, Annu. Rev. Immunol., 14, 233, 1996.
6. Mosmann, T.R. and Coffman, R.L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol., 7, 145, 1989.
7. Tough, D.F. and Sprent, J., Immunologic memory, in Fundamental Immunology, 5th ed., Paul, W.E., Lippincott Williams & Wilkins, Philadelphia, 2003.
8. Petrovsky, N. and Aguilar, J.C., Vaccine adjuvants: current state and future trends, Immunol. Cell. Biol., 82, 488, 2004.
9. Singh, M. and O'Hagan, D.T., Recent advances in veterinary vaccine adjuvants, Int. J. Parasitol., 33, 469, 2003.
10. Hanly, W.C., Artwohl, J.E., and Bennett, B.T., Review of polyclonal antibody production procedures in mammals and poultry, Ilar J., 37, 93, 1995.
11. Hunter, R.L., Olsen, M.R., and Bennett, B., Copolymer adjuvants and titermax, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
12. Stewart-Tull, D.E.S., Freund-type mineral oil adjuvant emulsions, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
13. Kenney, J.S., et al., Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies, J. Immunol. Methods, 121, 157, 1989.
14. Jennings, V.M., Review of selected adjuvants used in antibody production, Ilar J., 37, 119, 1995.
15. Topics in Vaccine Adjuvant Research, CRC Press, Boca Raton, FL, 1991. eds. Spriggs, Dale R., and Koff, Wayne C.
16. Stills, H.F., Jr., Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants, Ilar J., 46, 280, 2005.
17. Stewart-Tull, D.E.S., The Theory and Application of Adjuvants, John Wiley & Sons Ltd, West Sussex, England, 1995.
18. Freund, J., The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review, Am. J. Clin. Pathol., 21, 645, 1951.
19. NIH Intramural Recommendation for the use of Complete Freund's Adjuvant, ILAR News, 30, 1988.
20. Canadian Council on Animal Care, Guidelines on: Antibody Production, Ottawa, Ontario, Canada, 2002.
21. Hunter, R.L. and Bennett, B., The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers, J. Immunol., 133, 3167, 1984.
22. Howerton, D.A., et al., Induction of macrophage Ia expression in vivo by a synthetic block copolymer, L81, J. Immunol., 144, 1578, 1990.
23. Leenaars, P. P., et al., Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits, Vet. Immunol, Immunopathol., 40, 225, 1994.
24. Smith, D.E., et al., The selection of an adjuvant emulsion for polyclonal antibody production using a low-molecular-weight antigen in rabbits, Lab. Anim. Sci., 42, 599, 1992.
25. Tejada-Simon, M.V. and Pestka, J.J., Production of polyclonal antibody against ergosterol hemisuccinate using Freund's and Titermax adjuvants, J. Food Prot., 61, 1060, 1998.
26. Leenaars, P.P., et al., Assessment of side effects induced by injection of different adjuvant/antigen combinations in rabbits and mice, Lab. Anim., 32, 387, 1998.
27. Bennett, B., et al., A comparison of commercially available adjuvants for use in research, J. Immunol. Methods, 153, 31, 1992.
28. Ribi, E., et al., Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis, Cell Immunol., 16, 1, 1975.
29. Altman, A. and Dixon, F.J., Immunomodifiers in vaccines, Adv. Vet. Sci. Comp. Med., 33, 301, 1989.
30. Ellouz, F., et al., Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives, Biochem. Biophys. Res. Commun., 59, 1317, 1974.
31. Rudbach, J.A., Johnson, D.A., and Ulrich, J.T., Ribi adjuvants: chemistry, biology and utility in vaccines for human and veterinary medicine, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
32. Ribi, E., et al., Lipid A and immunotherapy, Rev. Infect. Dis., 6, 567, 1984.
33. Chiller, J.M., et al., Relationship of the structure of bacterial lipopolysaccharides to its function in mitogenesis and adjuvanticity, Proc. Natl. Acad. Sc. U. S. A., 70, 2129, 1973.
34. Kotani, S., et al., Immunobiological activities of synthetic lipid A analogs with low endotoxicity, Infect., Immun., 54, 673, 1986.
35. Deeb, B.J., et al., Comparison of Freund's and Ribi adjuvants for inducing antibodies to the synthetic antigen (TG)-AL in rabbits, J. Immunol. Methods, 152, 105, 1992.
36. Johnston, B.A., et al., An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits, Lab. Anim. Sci., 41, 15, 1991.
37. Lipman, N.S., et al., Comparison of immune response potentiation and in vivo inflammatory effects of Freund's and RIBI adjuvants in mice, Lab., Anim. Sci., 42, 193, 1992.
38. Mallon, F.M., et al., Comparison of antibody response by use of synthetic adjuvant system and Freund complete adjuvant in rabbits, Am. J. Vet. Res., 52, 1503, 1991.
39. Bokhout, B., et al., A selected water-in-oil emulsion: composition and usefulness as an immunological adjuvant, Vet. Immunol. Immunopathol., 2, 491, 1981.
40. Lindblad, E.B., Aluminium adjuvants, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
41. Allison, A.C. and Byars, N.E., Immunological adjuvants: desirable properties and side-effects, Mol. Immunol., 28, 279, 1991.
42. Leenaars, P.P., et al., Comparison of adjuvants for immune potentiating properties and side effects in mice, Vet. Immunol. Immunopathol., 48, 123, 1995.
43. Allison, A.C. and Gregoriadis, G., Liposomes as immunological adjuvants, Recent Results Cancer Res., 56, 58, 1976.
44. Gregoriadis, G., Liposomes as immunological adjuvants, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
45. Reddy, R., et al., Liposomes as antigen delivery systems in viral immunity, Semin. Immunol., 4, 91, 1992.
46. Takada, H. and Shozo, K., Muramy dipepetide and derivatives, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
47. Dalsgaard, K., et al., Immune stimulating complexes with Quil A, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
48. Sanders, M.T., et al., ISCOM-based vaccines: the second decade, Immunol. Cell. Biol., 83, 119, 2005.
49. Speijers, G.J., et al., Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine, Fundam. Appl. Toxicol., 10, 425, 1988.
50. Pearse, M.J. and Drane, D., ISCOMATRIX adjuvant for antigen delivery, Adv. Drug Deliv. Rev., 57, 465, 2005.
51. Dalpke, A.H. and Heeg, K., CpG-DNA as immune response modifier, Int. J. Med. Microbiol., 294, 345, 2004.
52. Klinman, D.M., CpG DNA as a vaccine adjuvant, Expert Rev. Vaccines, 2, 305, 2003.
53. Mutwiri, G.K., et al., Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides, J. Control Release, 97, 1, 2004.
54. Medzhitov, R. and Janeway, C.A., Jr., Innate immunity: the virtues of a nonclonal system of recognition, Cell, 91, 295, 1997.
55. Klinman, D.M., et al., Use of CpG oligodeoxynucleotides as immune adjuvants, Immunol. Rev., 199, 201, 2004.
56. Ada, G. and Ramshaw, I., DNA vaccination, Expert Opin. Emerg. Drugs, 8, 27, 2003.
57. Mutwiri, G., et al., Biological activity of immunostimulatory CpG DNA motifs in domestic animals, Vet. Immunol. Immunopathol., 91, 89, 2003.
58. Sasaki, S., et al., Adjuvant formulations and delivery systems for DNA vaccines, Methods, 31, 243, 2003.
59. Chambers, R.S. and Johnston, S.A., High-level generation of polyclonal antibodies by genetic immunization, Nat. Biotechnol., 21, 1088, 2003.
60. Johnston, S.A. and Tang, D.C., Gene gun transfection of animal cells and genetic immunization, Methods Cell. Biol., 43, 353, 1994.
61. Esche, U.v.d., et al., Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4, Int. J. Immunopharmacol., 22, 1093, 2000.
62. Kellner, J., et al., The influence of various adjuvants on antibody synthesis following immunization with an hapten, Biol. Chem. Hoppe Seyler, 373, 51, 1992.
63. Wu, J.Y., et al., Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice, Infect. Immunol., 69, 7695, 2001.
64. Holland, M.J., et al., Proteins secreted by the parasitic nematode Nippostrongylus brasiliensis act as adjuvants for Th2 responses, Eur. J. Immunol., 30, 1977, 2000.
65. Stevceva, L. and Ferrari, M.G., Mucosal adjuvants, Curr. Pharm. Des., 11, 801, 2005.
66. Barr, T.A., et al., A potent adjuvant effect of CD40 antibody attached to antigen, Immunology, 109, 87, 2003.
67. Carlring, J., et al., Anti-CD28 has a potent adjuvant effect on the antibody response to soluble antigens mediated through CTLA-4 by-pass, Eur. J. Immunol., 33, 135, 2003.
68. Hurn, B., Practical problems in raising antisera, Br. Med. Bull., 30, 26, 1974.
69. Byars, N.E. and Allison, A.C., Syntex adjuvant formulation, in The Theory and Application of Adjuvants, Stewart-Tull, D.E.S., John Wiley & Sons Ltd, West Sussex, England, 1995.
70. McCoy, K.L., et al., Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice, J. Immunol., 136, 1217, 1986.
71. Maurer, P.H. and Callahan, H.J., Proteins and polypeptides as antigens, Methods Enzymol., 70, 49, 1980.
72. Hu, J.G. and Kitagawa, T., Studies on the optimal immunization schedule of experimental animals. VI. Antigen dose-response of aluminum hydroxide-aided immunization and booster effect under low antigen dose, Chem. Pharm. Bull. (Tokyo), 38, 2775, 1990.
73. Zinkernagel, R.M., Localization dose and time of antigens determine immune reactivity, Semin. Immunol., 12, 163, 2000.
74. Hendriksen, C.F. and Hau, J., Production of Polyclonal and Monoclonal Antibodies, CRC Press, Boca Raton, FL, 2003.
75. Harlow, E. and Lane, D., Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988.
76. Hurn, B.A. and Chantler, S.M., Production of reagent antibodies, Methods Enzymol., 70, 104, 1980.
77. Muller, S., Immunization with peptides, in Synthetic Peptides as Antigens, Muller, S., Elsevier, Amsterdam, 1999.
78. Halliday, L.C., et al., Physiologic and behavioral assessment of rabbits immunized with Freund's complete adjuvant, Contemp. Top. Lab. Anim. Sci., 39, 8-, 2000.
79. Halliday, L.C., et al., Effects of Freund's complete adjuvant on the physiology, histology, and activity of New Zealand White Rabbits, Contemp. Top. Lab. Anim. Sci., 43, 2004.
80. Vaitukaitis, J.L., Production of antisera with small doses of immunogen: multiple intradermal injections, Methods Enzymol., 73, 46, 1981.
81. Stills, H.F., Jr. and Bailey, M., The use of Freund's complete adjuvant, Lab Anim., 20, 25, 1991.
82. Herbert, W.J., Mineral oil adjuvants and the immunization of laboratory animals, in Handbook of Experimental Immunology, 3rd ed., Weir, D.M., Blackwell Scientific Publications, Oxford, 1978.
83. Leskowitz, S. and Waksman, B.H., Studies on immunization. 1. The effect of route of injection of bovine serum albumin in Freund adjuvant on production of circulating antibody and delayed hypersensitivity, J. Immunol., 84, 58, 1960.
84. Herbert, W.J., Laboratory animal techniques for immunology, in Handbook of Experimental Immunology, 3rd ed., Weir, D.M., Blackwell Scientific Publications, Oxford, 1978.
85. O'Driscoll, C.M., Anatomy and physiology of the lymphatics, in Lymphatic Transport of Drugs, Charman, W.N. and Stella, V.J., CRC Press, Boca Raton, FL, 1992.
86. Amyx, H.L., Control of animal pain and distress in antibody production and infectious disease studies, J, Am. Vet. Med. Assoc., 191, 1287, 1987.
87. Schunk, M.K. and Macallum, G.E., Applications and optimization of immunization procedures, Ilar J., 46, 241., 2005.
88. Droual, R., et al., Investigation of problems associated with intramuscular breast injection of oil-adjuvanted killed vaccines in chickens, Avian Dis., 3, 473, 1990.
89. Stills, H.F., Polyclonal antibody production, in The Biology of the Laboratory Rabbits, 2nd ed., Manning, P.J., et al., Academic Press, San Diego, CA, 1994.
90. Ermeling, B.L., et al., Evaluation of subcutaneous chambers as an alternative to conventional methods of antibody production in chickens, Lab. Anim. Sci., 42, 402, 1992.
91. Clemons, D.J., et al., Evaluation of a subcutaneously implanted chamber for antibody production in rabbits, Lab. Anim. Sci., 42, 307, 1992.
92. Ried, J.L., et al., Production of polyclonal antibodies in rabbits is simplified using perforated plastic golf balls, Biotechniques, 12, 660, 1992.
93. Wolff, K.L., et al., Production of antibody in induced granulomas, J. Clin. Microbiol., 4, 384, 1976.
94. Hillam, R. P., et al., Local antibody production against the murine toxin of Yersinia pestis in a golf ball-induced granuloma, Infect. Immunol., 10, 458, 1974.
95. Hajer, I., et al., Immunoglobulin response to bluetongue virus soluble antigen in subcutaneous chambers, Am. J. Vet. Res., 38, 815, 1977.
96. Coghlan, L.G. and Hanausek, M., Subcutaneous immunization of rabbits with nitrocellulose paper strips impregnated with microgram quantities of protein, J. Immunol. Methods, 129, 135, 1990.
97. Herbert, W.J., The mode of action of mineral-oil emulsion adjuvants on antibody production in mice, Immunology, 14, 301, 1968.
98. Vaitukaitis, J., et al., A method for producing specific antisera with small doses of immunogen, J. Clin. Endocrinol. Metab., 33, 988, 1971.
99. Hillier, S.G., et al., The active immunisation of intact adult rats against steroid-protein conjugates: effects on circulating hormone levels and related physiological processes, in Steroid Immunoassay, Cameron, E.H.D., et al., Alpha Omega Publishing, Ltd., Cardiff, Wales, 1975.
100. Scaramuzzi, R.J., et al., Production of antisera to steroid hormones in sheep, in Steroid Immunoassay, Cameron, E.H.D., et al., Alpha Omega Publishing, Ltd., Cardiff, Wales, 1975.
101. Horne, C.H. and White, R.G., Evaluation of the direct injection of antigen into a peripheral lymph node for the production of humoral and cell-mediated immunity in the guinea-pig, Immunology, 15, 65, 1968.
102. Nilsson, B.O., et al., Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips, J. Immunol. Methods, 99, 67, 1987.
103. Hu, J.G., et al., Studies on the optimal immunization schedule of experimental animals. V. The effects of the route of injection, the content of Mycobacteria in Freund's adjuvant and the emulsifying antigen, Chem. Pharm. Bull. (Tokyo), 38, 1961, 1990.
104. Lader, S., et al., A comparative assessment of immunisation procedures for radioim-munoassays, in Radioimmunoassay and Related Procedures in Medicine, International Atomic Energy Agency, Vienna, 1974.
105. Chande, C., et al., Sequential study of IgG antibody response in immunized rabbit and development of immunization protocol for raising monospecific antibody, Indian J. Pathol. Microbiol., 39, 27, 1996.
106. Serody, J.S., et al., T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery, J. Immunol., 164, 4961, 2000.
107. Hu, J.G., et al., Studies on the optimal immunization schedule of experimental animals. IV. The optimal age and sex of mice, and the influence of booster injections, Chem. Pharm. Bull. (Tokyo), 38, 448, 1990.
108. Hu, Y.X., et al., Get effective polyclonal antisera in one month, Cell Res., 12, 157, 2002.
109. Leenaars, M. and Hendriksen, C.F., Critical steps in the production of polyclonal and monoclonal antibodies: evaluation and recommendations, Ilar J., 46, 269, 2005.
110. Larsson, A., et al., Chicken antibodies: taking advantage of evolution-a review, Poult. Sci., 72, 1807, 1993.
111. Tini, M.J., et al., Generation and application of chicken egg-yolk antibodies, Comp. Biochem. Physiol. A Mol. Integr. Physiol., 131, 569, 2002.
112. Schade, R., et al., The Production of Avian (Egg Yolk) Antibodies: IgY. The Report and Recommendations of ECVAM Workshop 21, 1994.
113. Khan, I.H., et al., Simultaneous serodetection of 10 highly prevalent mouse infectious pathogens in a single reaction by multiplex analysis, Clin. Diagn. Lab. Immunol., 12, 513, 2005.
114. Klaasen, H.L., et al., Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice, Infect. Immun., 61, 303, 1993.
115. O'Rourke, J., et al., Differences in the gastrointestinal microbiota of specific pathogen free mice: an often unknown variable in biomedical research, Lab. Anim., 22, 297, 1988.
116. Da Silva, J.A., Sex hormones and glucocorticoids: interactions with the immune system, Ann. N. Y. Acad. Sci., 876, 102, 1999.
117. de Groot, J., et al., Long-term effects of social stress on antiviral immunity in pigs, Physiol. Behav., 73, 145, 2001.
118. Konno, A., et al., Effects of a protein-free diet or food restriction on the immune system of Wistar and Buffalo rats at different ages, Mech. Ageing Dev., 72, 183, 1993.
119. Lopez-Varela, S., et al., Functional foods and the immune system: a review, Eur. J. Clin. Nutr., 56(Suppl 3), S29, 2002.
120. Kendall, L.V., et al., Antibody and cytokine responses to the Cilia-Associated Respiratory bacillus infected BALB/c and C57BL/6 mice, Infect. Immun., 68, 4961, 2000.
121. Snapper, C.M. and Finkelman, F.D., Immunoglobulin class switching, in Fundamental Immunology, 4th ed., Paul, W.E., Lippincott-Raven, Philadelphia, 1999.
122. Melo, M.E., et al., Strain-dependent effect of nasal instillation of antigen on the immune response in mice, Isr. Med. Assoc. J., 4(11 Suppl), 902, 2002.
123. Cartledge, C., et al., Production of polyclonal antibodies in ascitic fluid of mice: time and dose relationships, J. Immunoassay, 13, 339, 1992.
124. Kurpisz, M., et al., Production of large amounts of mouse polyclonal antisera, J. Immunol. Methods, 115, 195, 1988.
125. Lacy, M.J. and Voss, E.W., Jr., A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells, J. Immunol. Methods, 87, 169, 1986.
126. Mahana, W. and Paraf, A., Mice ascites as a source of polyclonal and monoclonal antibodies, J. Immunol. Methods, 161, 187, 1993.
127. Peterson, N.C., Behavioral, clinical, and physiologic analysis of mice used for ascites monoclonal antibody production, Comp. Med., 50, 516, 2000.
128. Jackson, L.R., et al., Monoclonal antibody production in murine ascites. I. Clinical and pathologic features, Lab. Anim. Sci. 49, 70, 1999.
129. Toth, L.A., et al., An evaluation of distress following intraperitoneal immunization with Freund's adjuvant in mice, Lab. Anim. Sci., 39, 122, 1989.
130. Svendsen Bollen, L., et al., Antibody production in rabbits and chickens immunized with human IgG. A comparison of titre and avidity development in rabbit serum, chicken serum and egg yolk using three different adjuvants, J. Immunol. Methods, 191, 113, 1996.
131. Wagner, A.E. and Dunlop, C.I., Anesthetic and medical management of acute hemorrhage during surgery, J. Am. Vet. Med. Assoc., 203, 40, 1993.
132. Diehl, K.H., et al., A good practice guide to the administration of substances and removal of blood, including routes and volumes, J. Appl. Toxicol., 21, 15, 2001.
133. 2000 Report of the AVMA Panel on Euthanasia, J. Am. Vet. Med. Assoc., 218, 669, 2001.
134. Cooper, H.M. and Paterson, Y., Production of antibodies, in Current Protocols in Immunology, Coligan, J.E., et al., John Wiley & Sons, Inc., 1995.
135. Tizard, I.R., Veterinary Immunology: An Introduction, 6th ed., W.B. Saunders Company, Philadelphia, 2000.
136. Hawk, C.T. and Leary, S.L., Formulary for Laboratory Animals, Iowa State University Press, Ames, 1995.
137. Flecknell, P., Laboratory Animal Anaesthesia: A Practical Introduction for Research Workers and Technicians, Academic Press, London, 1996.